Jason Lindsey, MD
Interventional Cardiology · Kansas City, MONPI 1043497241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Recor Medical Inc at 40.5% of the total. 2025 is the largest year on record at $545, 2.3 times the $232 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.
Across 26 payments — averaging $43.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Recor Medical Inc$457
- Abbott$253
- Organogenesis Inc.$120
- Medtronic$86
- Angiodynamics, Inc.$54
- Cagent Vascular Inc$38
- plus $121 from 4 others
Across 38 payments — averaging $2230.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$42K
- Recor Medical Inc$31K
- Philips North America LLC$12K
What the payments were for
- Food & beverage$1,10898%
- Education$202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Recor Medical Inc | 9 | $457 |
| Abbott | 6 | $253 |
| Organogenesis Inc. | 1 | $120 |
| Medtronic | 1 | $86 |
| Angiodynamics, Inc. | 1 | $54 |
| Cagent Vascular Inc | 1 | $38 |
| Boston Scientific | 3 | $37 |
| Penumbra, Inc. | 2 | $34 |
| Teleflex LLC | 1 | $30 |
| CSL Behring | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,128 in reported general payments places this provider in the 10th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 227 | $228,538 |
| JardianceEmpagliflozin | 109 | $98,636 |
| OzempicSemaglutide | 38 | $58,029 |
| XareltoRivaroxaban | 46 | $40,214 |
| EntrestoSacubitril/Valsartan | 28 | $37,501 |
| Repatha SureclickEvolocumab | 31 | $24,775 |
| Repatha SyringeEvolocumab | 22 | $23,469 |
| Praluent PenAlirocumab | 24 | $13,634 |
| MounjaroTirzepatide | 11 | $12,240 |
| Flecainide Acetate | 31 | $2,024 |
| Ezetimibe | 95 | $1,728 |
| Metoprolol Succinate | 102 | $1,701 |
| Atorvastatin Calcium | 175 | $1,536 |
| Ranolazine ErRanolazine | 12 | $1,439 |
| Spironolactone | 186 | $1,361 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Kansas City
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
- Adnan ChhatriwallaKansas City$114K
- Kenneth HuberKansas City$110K
- Chetan HudedKansas City$61K
- Adam SalisburyKansas City$52K
- Steven MarsoKansas City$42K
- Dany JacobKansas City$35K
- Muhammad Anis HaiderKansas City$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.